nanobiotix

LAURENT LEVY, PhD, has a deep understanding of the technical, scientific, intellectual property and marketing issues associated with nanotechnologies, because he has been working-and achieving- in these areas for more than a decade. His pioneering research at the frontier of molecular biology and physics has empowered him to develop a number of practical applications, not the least of which is nanoXray, the technology foundation of Nanobiotix, which is focused on making possible a whole new era in cancer medicine. Laurent Levy has worked for many years as a consultant in business development and in the implementation of nanotechnologies with major companies, including Sanofi Aventis, Guerbet, and Rhodia, as well as start-up biotechs.

He is the president of the French Technology Platform of Nanomedicine (FTPN) and is involved with many international groups working in the field. The author of 35 international publications and communications, Dr.  Levy holds several patents and completed postdoctoral work at the Institute for Laser Photonics and Biophotonics, State University of New York (SUNY), Buffalo.  Dr. Levy holds a PhD in Physical Chemistry specializing in Nanomaterials from Pierre et Marie Curie University-CEA, and a DEA (first doctoral diploma) in Condensed Matter from UPVIESPCI (Paris).